ArticleOncotarget2018

Correction: Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromes.

M Teresa Cedena et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.